251 – 260 of 274
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Erythropoietin suppresses the activation of pro-apoptotic genes in head and neck squamous cell carcinoma xenografts exposed to surgical trauma.
- Contribution to journal › Article
-
Mark
Human anaplastic thyroid carcinoma cells are sensitive to NK cell-mediated lysis via ULBP2/5/6 and chemoattract NK cells
- Contribution to journal › Article
-
Mark
Expression of allergy-associated C-type lectin receptors by DC subsets is modified by allergen-specific immunotherapy
(2014) The European Academy of Allergy and Clinical Immunology Conference
- Contribution to conference › Abstract
-
Mark
Human blood dendritic cell subsets exhibit discriminative pattern recognition recep-tor profiles
(2014) 13th International Conference on Dendritic Cells
- Contribution to conference › Abstract
-
Mark
188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors : preclinical assessment
(2014) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine 55(11). p.8-1842
- Contribution to journal › Article
- 2013
-
Mark
Cell-line-specific stimulation of tumor cell aggressiveness by wound healing factors - a central role for STAT3
- Contribution to journal › Article
-
Mark
Preclinical radioimmunotherapy of prostate cancer with 177Lu-11B6, a 177Lu-labeled monoclonal antibody specifically targeting free, unbound human kallikrein-related peptidase 2
- Contribution to journal › Published meeting abstract
- 2012
-
Mark
Targeting Free Prostate-Specific Antigen for In Vivo Imaging of Prostate Cancer Using a Monoclonal Antibody Specific for Unique Epitopes Accessible on Free Prostate-Specific Antigen Alone.
- Contribution to journal › Article
-
Mark
Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines.
- Contribution to journal › Article
-
Mark
The anti-tumour effect of cisplatin and ifosfamide on xenografted squamous cell carcinoma of the head and neck is schedule-dependent.
- Contribution to journal › Article
